Company
Those With A Risk-Tolerant Portfolio Can Expect A Bright Future From Aclaris Therapeutics Inc (NASDAQ: ACRS)
During the last session, Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares were 0.83 million, with the beta value of the company hitting 0.42. At the end